Brain Implant Market By Type (Deep brain stimulation, Vagus nerve stimulation), By Application (Parkinson's disease, Epilepsy, Others), By End User (Hospitals, Neurology clinics, Others): Global Opportunity Analysis and Industry Forecast, 2023-2032
Market Report I 2023-04-01 I 250 Pages I Allied Market Research
The brain implant market valued for $1.4 billion in 2022 and is estimated to reach $4.5 billion by 2032, exhibiting a CAGR of 12.2% from 2023 to 2032.
Abrain implant is a medical device that is surgically implanted into the brain to monitor or control brain functions. Brain implantare also known as neural implants,neuroprosthetics, or brain-computer interfaces (BCIs). They are designed to help restore lost function or improve quality of life for those with neurological disordersor injuries. Several types of brain implantare there, each designed to serve a specific purpose. Some brain implantare used to treat neurological disorders such asParkinson's disease and epilepsy. These implants work by delivering electrical impulses to specific regions of the brain to alleviate symptoms. In addition, comparedto traditional medications, electrical stimulation of nerves can offer several advantages, such as targeted and adjustable stimulation, reduces risk of systemic sideeffects, and the potential for long-term benefits.
The global brain implantmarket growth is majorly driven by rise in prevalence of lifestyle diseases such as depression, increase in number of neurological disorders,and investment for neurological R&D. For instance, according to World Health Organization (WHO), more than 1 billion people throughout the world are affected by sometype of neurological disease. Thus, prevalence of such conditions drives the demand for brain implantto manage and treat the neurological conditions. Moreover,adoption of technologically advanced products and surge in aging population propel the growth of the market as they are more susceptible to neurological disorders,such as epilepsy and parkinson's disease.
However, high costs associated with brain implantand the lack of skilled personnel in some countries hinder market growth to some extent. In addition, side effectssuch as allergic reaction due to implantation of device into the body and availability of other treatment options such as drug therapies and surgeries limit the growthof the market.
Moreover, development and technological advancements have improved the effectiveness and accessibility of brain implant, which is expected to drive the market growth.Furthermore, surge in awareness among healthcare providers and patients about advantages of brain implant, to treat a variety of conditions, is expected to drivedemand in the market during the forecast period.
The brain implantmarket is segmented into type, application, end user, and region. By type, the market is categorized into deep brain stimulationand vagus nervestimulation. By application, the market is classified into Parkinson's disease, epilepsy and others. By end user, the market is divided into hospitals, neurologyclinics and others. Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest ofEurope), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major key players that operate in the global brain implantmarket are Abbott Laboratories, Aleva Neurotherapeutics SA, Boston scientific corporation, FunctionalNeuromodulation Ltd., Medtronic plc, NeuroPace Inc., Beijing PINS Medical Co., Ltd, LivaNova PLC., MicroTransponder Inc. and SceneRay Co., Ltd. Key players operating in the market have adopted product approval and product launch as their key strategies to expand their product portfolio.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the brain implant market analysis from 2022 to 2032 to identify the prevailing brain implant market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the brain implant market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global brain implant market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- Deep brain stimulation
- Vagus nerve stimulation
By Application
- Parkinson's disease
- Epilepsy
- Others
By End User
- Hospitals
- Neurology clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Abbott Laboratories
- Aleva Neurotherapeutics SA
- Beijing PINS Medical Co., Ltd
- Boston Scientific Corporation
- Functional Neuromodulation, Ltd.
- LivaNova PLC
- Medtronic plc
- MicroTransponder Inc.
- NeuroPace, Inc.
- SceneRay Co., Ltd.
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Increase in prevalence neurological disorder
3.4.1.2. Initiatives by government and non-government organizations
3.4.1.3. Rise in geriatric population
3.4.2. Restraints
3.4.2.1. High cost of brain implants
3.4.3. Opportunities
3.4.3.1. Rise in technological advancements
3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: BRAIN IMPLANT MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Deep brain stimulation
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Vagus nerve stimulation
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
CHAPTER 5: BRAIN IMPLANT MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Parkinson's disease
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Epilepsy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Others
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
CHAPTER 6: BRAIN IMPLANT MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Neurology clinics
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: BRAIN IMPLANT MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Type
7.2.5.1.3. Market size and forecast, by Application
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Type
7.2.5.2.3. Market size and forecast, by Application
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Type
7.2.5.3.3. Market size and forecast, by Application
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Type
7.3.5.1.3. Market size and forecast, by Application
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Type
7.3.5.2.3. Market size and forecast, by Application
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Type
7.3.5.3.3. Market size and forecast, by Application
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Type
7.3.5.4.3. Market size and forecast, by Application
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Type
7.3.5.5.3. Market size and forecast, by Application
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Type
7.3.5.6.3. Market size and forecast, by Application
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Type
7.4.5.1.3. Market size and forecast, by Application
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Type
7.4.5.2.3. Market size and forecast, by Application
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Type
7.4.5.3.3. Market size and forecast, by Application
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Type
7.4.5.4.3. Market size and forecast, by Application
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Type
7.4.5.5.3. Market size and forecast, by Application
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Type
7.4.5.6.3. Market size and forecast, by Application
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Type
7.5.5.1.3. Market size and forecast, by Application
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Type
7.5.5.2.3. Market size and forecast, by Application
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Type
7.5.5.3.3. Market size and forecast, by Application
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Type
7.5.5.4.3. Market size and forecast, by Application
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Boston Scientific Corporation
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.1.7. Key strategic moves and developments
9.2. Medtronic plc
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. LivaNova PLC
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Aleva Neurotherapeutics SA
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Key strategic moves and developments
9.5. NeuroPace, Inc.
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.5.6. Business performance
9.6. Functional Neuromodulation, Ltd.
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Beijing PINS Medical Co., Ltd
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. Abbott Laboratories
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.8.6. Business performance
9.8.7. Key strategic moves and developments
9.9. SceneRay Co., Ltd.
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. MicroTransponder Inc.
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
LIST OF TABLES
TABLE 01. GLOBAL BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 02. BRAIN IMPLANT MARKET FOR DEEP BRAIN STIMULATION, BY REGION, 2022-2032 ($MILLION)
TABLE 03. BRAIN IMPLANT MARKET FOR VAGUS NERVE STIMULATION, BY REGION, 2022-2032 ($MILLION)
TABLE 04. GLOBAL BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 05. BRAIN IMPLANT MARKET FOR PARKINSON'S DISEASE, BY REGION, 2022-2032 ($MILLION)
TABLE 06. BRAIN IMPLANT MARKET FOR EPILEPSY, BY REGION, 2022-2032 ($MILLION)
TABLE 07. BRAIN IMPLANT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 08. GLOBAL BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 09. BRAIN IMPLANT MARKET FOR HOSPITALS, BY REGION, 2022-2032 ($MILLION)
TABLE 10. BRAIN IMPLANT MARKET FOR NEUROLOGY CLINICS, BY REGION, 2022-2032 ($MILLION)
TABLE 11. BRAIN IMPLANT MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
TABLE 12. BRAIN IMPLANT MARKET, BY REGION, 2022-2032 ($MILLION)
TABLE 13. NORTH AMERICA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 14. NORTH AMERICA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 15. NORTH AMERICA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 16. NORTH AMERICA BRAIN IMPLANT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 17. U.S. BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 18. U.S. BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 19. U.S. BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 20. CANADA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 21. CANADA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 22. CANADA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 23. MEXICO BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 24. MEXICO BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 25. MEXICO BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 26. EUROPE BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 27. EUROPE BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 28. EUROPE BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 29. EUROPE BRAIN IMPLANT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 30. GERMANY BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 31. GERMANY BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 32. GERMANY BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 33. FRANCE BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 34. FRANCE BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 35. FRANCE BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 36. UK BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 37. UK BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 38. UK BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 39. ITALY BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 40. ITALY BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 41. ITALY BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 42. SPAIN BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 43. SPAIN BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 44. SPAIN BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 45. REST OF EUROPE BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 46. REST OF EUROPE BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 47. REST OF EUROPE BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 48. ASIA-PACIFIC BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 49. ASIA-PACIFIC BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 50. ASIA-PACIFIC BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 51. ASIA-PACIFIC BRAIN IMPLANT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 52. JAPAN BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 53. JAPAN BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 54. JAPAN BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 55. CHINA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 56. CHINA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 57. CHINA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 58. INDIA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 59. INDIA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 60. INDIA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 61. AUSTRALIA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 62. AUSTRALIA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 63. AUSTRALIA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 64. SOUTH KOREA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 65. SOUTH KOREA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 66. SOUTH KOREA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 67. REST OF ASIA-PACIFIC BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 68. REST OF ASIA-PACIFIC BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 70. LAMEA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 71. LAMEA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 72. LAMEA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 73. LAMEA BRAIN IMPLANT MARKET, BY COUNTRY, 2022-2032 ($MILLION)
TABLE 74. BRAZIL BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 75. BRAZIL BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 76. BRAZIL BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 77. SAUDI ARABIA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 78. SAUDI ARABIA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 79. SAUDI ARABIA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 80. SOUTH AFRICA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 81. SOUTH AFRICA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 82. SOUTH AFRICA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 83. REST OF LAMEA BRAIN IMPLANT MARKET, BY TYPE, 2022-2032 ($MILLION)
TABLE 84. REST OF LAMEA BRAIN IMPLANT MARKET, BY APPLICATION, 2022-2032 ($MILLION)
TABLE 85. REST OF LAMEA BRAIN IMPLANT MARKET, BY END USER, 2022-2032 ($MILLION)
TABLE 86. BOSTON SCIENTIFIC CORPORATION: KEY EXECUTIVES
TABLE 87. BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
TABLE 88. BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTS
TABLE 89. BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
TABLE 90. BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
TABLE 91. MEDTRONIC PLC: KEY EXECUTIVES
TABLE 92. MEDTRONIC PLC: COMPANY SNAPSHOT
TABLE 93. MEDTRONIC PLC: PRODUCT SEGMENTS
TABLE 94. MEDTRONIC PLC: PRODUCT PORTFOLIO
TABLE 95. MEDTRONIC PLC: KEY STRATERGIES
TABLE 96. LIVANOVA PLC: KEY EXECUTIVES
TABLE 97. LIVANOVA PLC: COMPANY SNAPSHOT
TABLE 98. LIVANOVA PLC: PRODUCT SEGMENTS
TABLE 99. LIVANOVA PLC: PRODUCT PORTFOLIO
TABLE 100. LIVANOVA PLC: KEY STRATERGIES
TABLE 101. ALEVA NEUROTHERAPEUTICS SA: KEY EXECUTIVES
TABLE 102. ALEVA NEUROTHERAPEUTICS SA: COMPANY SNAPSHOT
TABLE 103. ALEVA NEUROTHERAPEUTICS SA: PRODUCT SEGMENTS
TABLE 104. ALEVA NEUROTHERAPEUTICS SA: PRODUCT PORTFOLIO
TABLE 105. ALEVA NEUROTHERAPEUTICS SA: KEY STRATERGIES
TABLE 106. NEUROPACE, INC.: KEY EXECUTIVES
TABLE 107. NEUROPACE, INC.: COMPANY SNAPSHOT
TABLE 108. NEUROPACE, INC.: PRODUCT SEGMENTS
TABLE 109. NEUROPACE, INC.: PRODUCT PORTFOLIO
TABLE 110. FUNCTIONAL NEUROMODULATION, LTD.: KEY EXECUTIVES
TABLE 111. FUNCTIONAL NEUROMODULATION, LTD.: COMPANY SNAPSHOT
TABLE 112. FUNCTIONAL NEUROMODULATION, LTD.: PRODUCT SEGMENTS
TABLE 113. FUNCTIONAL NEUROMODULATION, LTD.: PRODUCT PORTFOLIO
TABLE 114. BEIJING PINS MEDICAL CO., LTD: KEY EXECUTIVES
TABLE 115. BEIJING PINS MEDICAL CO., LTD: COMPANY SNAPSHOT
TABLE 116. BEIJING PINS MEDICAL CO., LTD: PRODUCT SEGMENTS
TABLE 117. BEIJING PINS MEDICAL CO., LTD: PRODUCT PORTFOLIO
TABLE 118. ABBOTT LABORATORIES: KEY EXECUTIVES
TABLE 119. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 120. ABBOTT LABORATORIES: PRODUCT SEGMENTS
TABLE 121. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 122. ABBOTT LABORATORIES: KEY STRATERGIES
TABLE 123. SCENERAY CO., LTD.: KEY EXECUTIVES
TABLE 124. SCENERAY CO., LTD.: COMPANY SNAPSHOT
TABLE 125. SCENERAY CO., LTD.: PRODUCT SEGMENTS
TABLE 126. SCENERAY CO., LTD.: PRODUCT PORTFOLIO
TABLE 127. MICROTRANSPONDER INC.: KEY EXECUTIVES
TABLE 128. MICROTRANSPONDER INC.: COMPANY SNAPSHOT
TABLE 129. MICROTRANSPONDER INC.: PRODUCT SEGMENTS
TABLE 130. MICROTRANSPONDER INC.: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. BRAIN IMPLANT MARKET, 2022-2032
FIGURE 02. SEGMENTATION OF BRAIN IMPLANT MARKET, 2022-2032
FIGURE 03. TOP INVESTMENT POCKETS IN BRAIN IMPLANT MARKET (2023-2032)
FIGURE 04. LOW BARGAINING POWER OF SUPPLIERS
FIGURE 05. LOW BARGAINING POWER OF BUYERS
FIGURE 06. LOW THREAT OF SUBSTITUTES
FIGURE 07. LOW THREAT OF NEW ENTRANTS
FIGURE 08. LOW INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALBRAIN IMPLANT MARKET
FIGURE 10. BRAIN IMPLANT MARKET, BY TYPE, 2022(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF BRAIN IMPLANT MARKET FOR DEEP BRAIN STIMULATION, BY COUNTRY 2022 AND 2032(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF BRAIN IMPLANT MARKET FOR VAGUS NERVE STIMULATION, BY COUNTRY 2022 AND 2032(%)
FIGURE 13. BRAIN IMPLANT MARKET, BY APPLICATION, 2022(%)
FIGURE 14. COMPARATIVE SHARE ANALYSIS OF BRAIN IMPLANT MARKET FOR PARKINSON'S DISEASE, BY COUNTRY 2022 AND 2032(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF BRAIN IMPLANT MARKET FOR EPILEPSY, BY COUNTRY 2022 AND 2032(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF BRAIN IMPLANT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 17. BRAIN IMPLANT MARKET, BY END USER, 2022(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF BRAIN IMPLANT MARKET FOR HOSPITALS, BY COUNTRY 2022 AND 2032(%)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF BRAIN IMPLANT MARKET FOR NEUROLOGY CLINICS, BY COUNTRY 2022 AND 2032(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF BRAIN IMPLANT MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
FIGURE 21. BRAIN IMPLANT MARKET BY REGION, 2022
FIGURE 22. U.S. BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 23. CANADA BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 24. MEXICO BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 25. GERMANY BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 26. FRANCE BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 27. UK BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 28. ITALY BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 29. SPAIN BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 30. REST OF EUROPE BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 31. JAPAN BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 32. CHINA BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 33. INDIA BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 34. AUSTRALIA BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 35. SOUTH KOREA BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 36. REST OF ASIA-PACIFIC BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 37. BRAZIL BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 38. SAUDI ARABIA BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 39. SOUTH AFRICA BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 40. REST OF LAMEA BRAIN IMPLANT MARKET, 2022-2032 ($MILLION)
FIGURE 41. TOP WINNING STRATEGIES, BY YEAR
FIGURE 42. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 43. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 44. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 45. COMPETITIVE DASHBOARD
FIGURE 46. COMPETITIVE HEATMAP: BRAIN IMPLANT MARKET
FIGURE 47. TOP PLAYER POSITIONING, 2022
FIGURE 48. BOSTON SCIENTIFIC CORPORATION: NET SALES, 2020-2022 ($MILLION)
FIGURE 49. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 50. BOSTON SCIENTIFIC CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 51. MEDTRONIC PLC: NET SALES, 2020-2022 ($MILLION)
FIGURE 52. MEDTRONIC PLC: REVENUE SHARE BY SEGMENT, 2022 (%)
FIGURE 53. MEDTRONIC PLC: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 54. LIVANOVA PLC: NET REVENUE, 2019-2021 ($MILLION)
FIGURE 55. LIVANOVA PLC: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 56. LIVANOVA PLC: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 57. NEUROPACE, INC.: NET REVENUE, 2020-2022 ($MILLION)
FIGURE 58. ABBOTT LABORATORIES: NET SALES, 2020-2022 ($MILLION)
FIGURE 59. ABBOTT LABORATORIES: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
FIGURE 60. ABBOTT LABORATORIES: REVENUE SHARE BY REGION, 2022 (%)
FIGURE 61. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2022 (%)
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.